Beijing, China

Lili Jiang

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lili Jiang. Retrieved from https://idiyas.com/inventor/lili-jiang-xjg5ru8o

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lili Jiang - Innovator in Chemical and Biological Engineering

Introduction

Lili Jiang is a prominent inventor based in Beijing, China. She has made significant contributions to the field of chemical and biological engineering. Her innovative work focuses on enhancing the stability and efficiency of mRNA through her patented inventions.

Latest Patents

Lili Jiang holds a patent for a ribose-modified cap analog, which is designed to improve the stability of mRNA and enhance its translation efficiency. This invention belongs to the technical field of chemical and biological engineering and has the potential to impact various applications in biotechnology.

Career Highlights

Lili Jiang is associated with Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd., where she applies her expertise in developing advanced pharmaceutical technologies. Her work is characterized by a commitment to innovation and excellence in her field.

Collaborations

Lili collaborates with notable colleagues, including Honglei Zhang and Gengshen Song, who contribute to her research and development efforts. Their teamwork fosters a creative environment that drives innovation.

Conclusion

Lili Jiang's contributions to the field of chemical and biological engineering exemplify her dedication to advancing technology. Her patented ribose-modified cap analog represents a significant step forward in mRNA research and applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…